fda approval of tirzepatide for weight loss Grants a New Indication Obesity Management FDA approves new version of

Tune in to hear Suzy Badaracco, president of Culinary Tides, and Sherry Frey, vice president, Total Wellness, NielsenIQ, in a conversation guided by Michael Costa, managing editor of Food Business News , as they highlight the effect GLP-1 medications are having on consumer packaged goods companies

and Ghorpade et al

A pilot clinical study by Sasaninia et al

DAMPs also impact Kupffer cells, activating the nucleotide-binding oligomerization domain-like receptor (NLR) Family, Pyrin Domain-Containing 3 protein (NLRP3), a type of inflammasome leading to IL-1 secretion and inflammation, and pyroptosis, releasing more DAMPs and perpetuating a destructive cycle (Hammerich and Tacke, 2023)